Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pfizer Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
PFE
New York
2830
www.pfizer.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pfizer Inc.
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...
- Aug 6th, 2026 5:19 pm
NVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot — Retail Eyes Buyout, More Partnership Deals
- Aug 6th, 2026 3:29 pm
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine
- Aug 6th, 2026 12:01 pm
After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?
- Aug 6th, 2026 10:00 am
Boomers Should Buy These High-Yield Dividend August Bargains Hand-Over-Fist
- Aug 6th, 2026 6:46 am
Pfizer (PFE) Could Be 12% Undervalued Following Raised 2026 Revenue Guidance
- Aug 5th, 2026 6:17 pm
Why PFE Stock Hands You So Much Cash Right Now
- Aug 5th, 2026 3:23 pm
3 Beaten-Down Stocks to Hold for the Next 10 Years
- Aug 5th, 2026 1:18 pm
Pfizer Stock Slips Despite Earnings Beat and $2.5 Billion Cuts
- Aug 5th, 2026 9:04 am
Health Canada Approves KEYTRUDA® for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after radical cystectomy as adjuvant treatment
- Aug 5th, 2026 9:00 am
Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts
- Aug 5th, 2026 8:00 am
Pfizer Q2 Earnings Call Highlights
- Aug 5th, 2026 6:04 am
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
- Aug 5th, 2026 5:00 am
Company News for Aug 5, 2026
- Aug 5th, 2026 4:09 am
Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive
- Aug 4th, 2026 11:17 pm
Pfizer Inc. Q2 2026 Earnings Call Summary
- Aug 4th, 2026 4:50 pm
Pfizer Ducks Continued Covid Fallout As Hard-Fought Obesity Readout Looms
- Aug 4th, 2026 3:31 pm
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
- Aug 4th, 2026 3:27 pm
SpaceX, Palantir, AMD, Marvell, Caterpillar, Pfizer, and More Stocks That Explain Today’s Market
- Aug 4th, 2026 2:34 pm
Pfizer Earnings Reveal New Engine Beyond Covid
- Aug 4th, 2026 1:55 pm
Scroll